OOIR: Observatory of International Research

Papers

(The H4-Index of International Forum of Allergy & Rhinology is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Smell dysfunction: a biomarker for COVID‐19	550
Association of chemosensory dysfunction and COVID‐19 in patients presenting with influenza‐like symptoms	536
International consensus statement on allergy and rhinology: rhinosinusitis 2021	389
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies	259
Self‐reported olfactory loss associates with outpatient clinical course in COVID‐19	254
Potential pathogenesis of ageusia and anosmia in COVID‐19 patients	190
Use of Google Trends to investigate loss‐of‐smell‒related searches during the COVID‐19 outbreak	175
Review of indoor aerosol generation, transport, and control in the context of COVID‐19	115
Smell and taste alterations in COVID‐19: a cross‐sectional analysis of different cohorts	95
A primer on viral‐associated olfactory loss in the era of COVID‐19	95
Smell and taste symptom‐based predictive model for COVID‐19 diagnosis	88
Coronavirus disease 2019 (COVID‐19)–related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome–coronavirus‐2 (SARS‐CoV‐2) Omicron variant	76
Prevalence and reversibility of smell dysfunction measured psychophysically in a cohort of COVID‐19 patients	74
Sequelae in adults at 12 months after mild‐to‐moderate coronavirus disease 2019 (COVID‐19)	69
Treatment of post‐viral olfactory dysfunction: an evidence‐based review with recommendations	65
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023	62
Fulminant mucormycosis complicating coronavirus disease 2019 (COVID‐19)	55
Psychophysical tests reveal impaired olfaction but preserved gustation in COVID‐19 patients	54
Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps	46
International Consensus Statement on Obstructive Sleep Apnea	46
International consensus statement on allergy and rhinology: Olfaction	45
Systemic corticosteroids in coronavirus disease 2019 (COVID‐19)‐related smell dysfunction: an international view	43
Management of odontogenic sinusitis: multidisciplinary consensus statement	42
Skull‐base surgery during the COVID‐19 pandemic: the Italian Skull Base Society recommendations	41
The roles of eosinophils and interleukin‐5 in the pathophysiology of chronic rhinosinusitis with nasal polyps	40

International Consensus Statement: Spontaneous Cerebrospinal Fluid Rhinorrhea	39
Diagnosing odontogenic sinusitis: An international multidisciplinary consensus statement	38
A systematic review to examine the relationship between objective and patient‐reported outcome measures in sinonasal disorders: recommendations for use in research and clinical practice	31
Volumetric assessment of paranasal sinus opacification on computed tomography can be automated using a convolutional neural network	30
Interim analysis of an open‐label randomized controlled trial evaluating nasal irrigations in non‐hospitalized patients with coronavirus disease 2019	30